At Motric Bio, we’re on a mission to improve the lives of people with muscle spasticity and enable them to gain function and freedom to actively enjoy life.
Our lead product candidate, MTR-601, represents a bold scientific advance that overcomes the challenges of selective targeting of myosin-2. In developing MTR-601 we have identified a single amino acid protein (L476), where the fast-twitch skeletal myosin-2 differs from all other myosin-2 isoforms in the body. Identifying this key variation enables MTR-601 to be rationally designed with a unique mechanism of action that specifically blocks fast-twitch skeletal muscle – without affecting cardiac and smooth muscle types.
Company Details
- Employees
- 2
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.motricbio.com
Motric Bio Questions
Motric Bio's website is http://www.motricbio.com
Motric Bio's LinkedIn profile is https://www.linkedin.com/company/motric-bio
Motric Bio has
2 employees.
View email and phone details for 2
employees at Motric Bio.
Motric Bio's industry is
Biotechnology Research
Motric Bio's top competitors are
Via Nova Therapeutics,
Aditum Bio,
Kainos Medicine, Inc.,
Envveno Medical,
Tempero Bio,
Codera, Llc,
Caliway Biopharmaceuticals,
Anteris Bio,
Supercede Therapeutics, Inc.,
The Human Lens.
Motric Bio's categories are Biotechnology Research
